A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock.

Adrian WongAfrah AlkazemiI Mary EcheCamille R PetriTodd SargeMichael N Cocchi

Published in: Journal of intensive care medicine (2019)

In this cohort, ATII appears to be well tolerated in patients with a high predicted mortality. Future studies evaluating the clinical efficacy of ATII are needed to determine its role in the management of distributive shock.

Keyphrases

angiotensin ii
angiotensin converting enzyme
vascular smooth muscle cells
cardiovascular events
current status
risk factors
case control
type diabetes
cardiovascular disease
coronary artery disease